6 completed, 2 recruiting, 2 terminated. 10 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 6, Recruiting 2, Terminated 2 |
| Phase 3 | 1 | Completed 1 |
Follow Acute Chest Syndrome: new trials by email Literature Review of Acute Chest Syndrome trials Research Report on Acute Chest Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis CSL889, Placebo - Sickle Cell Disease Vaso-occlusive Crisis | Phase 2 | Recruiting | CSL Behring | 70 | 2025-07-10 | 2026-10-08 |
| Tocilizumab for Acute Chest Syndrome Tocilizumab - Sickle Cell Disease, Acute Chest Syndrome | Phase 2 | Recruiting | University of Chicago | 200 | 2023-04-10 | 2026-09-15 |
| Daily Vitamin D for Sickle-cell Respiratory Complications Daily oral vitamin D3, 3,333 IU, Monthly oral vitamin D3, 100,000 IU, Placebo oral tablet - Sickle Cell Disease, Anemia, Sickle Cell | Phase 2 | Completed | Columbia University | 58 | 2020-09-15 | 2025-09-24 |
| Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome Defibrotide - Sickle Cell Disease, Acute Chest Syndrome | Phase 2 | Completed | New York Medical College | 20 | 2018-01-12 | 2023-12-08 |
| Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome Unfractionated heparin - Acute Chest Syndrome, Sickle Cell Disease | Phase 2 | Terminated | Craig Seaman | 7 | 2014-05-01 | 2019-07-16 |
| Vitamin D for Sickle-cell Respiratory Complications Experimental: Vitamin D3 100,000 IU, Active Comparator: Vitamin D3 12,000 IU - Sickle Cell Disease, Vitamin D Deficiency | Phase 2 | Completed | Gary M Brittenham, MD | 70 | 2011-12-13 | 2024-08-09 |
| Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children Nitric oxide by inhalation INOMAX, Placebo - Acute Chest Syndrome, Sickle Cell Disease | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 21 | 2010-06-01 | 2014-12-04 |
| Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study) Nitric Oxide, Placebo - Sickle Cell Disease, Acute Chest Syndrome | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 100 | 2008-12-01 | 2013-08-02 |
| Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease Hydroxyurea, Magnesium Pidolate, Placebo Pills and Placebo Liquid - Hemoglobin SC Disease | Phase 2 | Terminated | St. Jude Children's Research Hospital | 44 | 2007-01-01 | 2013-01-18 |
| IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome A-001, Placebo - Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | Completed | Anthera Pharmaceuticals | 30 | 2006-12-01 | 2014-03-04 |
Anemia, Sickle Cell (10) · Vaso-Occlusive Crises (3) · Asthma (2) · Respiratory Tract Infections (2) · Vitamin D Deficiency (2) · Acute Kidney Injury (1) · Acute Lung Injury (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Avitaminosis (1) · Hemoglobin SC Disease (1) · Hemoglobinopathies (1) · Lung Diseases (1) · Nutrition Disorders (1)
Anemia (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Genetic Diseases, Inborn (10) · Hematologic Diseases (10) · Hemic and Lymphatic Diseases (10) · Anemia, Hemolytic (9) · Anemia, Hemolytic, Congenital (9) · Hemoglobinopathies (9) · Lung Diseases (9) · Respiration Disorders (9) · Respiratory Tract Diseases (9) · Bronchial Diseases (2) · Deficiency Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2)
Cholecalciferol (2) · Administration, Oral (1) · Endothelium-Dependent Relaxing Factors (1) · Hemopexin (1) · Heparin (1) · Hydroxyurea (1) · Nitric Oxide (1) · Pyrrolidonecarboxylic Acid (1) · defibrotide (1) · tocilizumab (1)
Assistance Publique - Hôpitaux de Paris (2) · Anthera Pharmaceuticals (1) · CSL Behring (1) · Columbia University (1) · Craig Seaman (1) · Gary M Brittenham, MD (1) · New York Medical College (1) · St. Jude Children's Research Hospital (1) · University of Chicago (1)
United States (8) · France (2) · Turkey (Türkiye) (1) · United Kingdom (1)
Craig D Seaman, MD (1) · Gabrielle Lapping-Carr, MD (1) · Gary Brittenham, MD (1) · Gary M Brittenham, MD (1) · Malika Benkerrou, Dr. (1) · Margaret Ragni, MD, MPH (1) · Margaret T Lee, MD (1) · Margaret T. Lee, MD (1) · Mitchell S Cairo, MD (1) · Winfred C. Wang, MD (1)
PMID 21275961, PMID 26431718, PMID 29712666
U54HL070587 (1)